Related Experiment Video
Updated: May 28, 2026
12:01
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
α-Synuclein levels modulate Huntington's disease in mice.
Silvia Corrochano1, Maurizio Renna, Sarah Carter
1MRC Mammalian Genetics Unit, Harwell, Oxfordshire OX11 0RD, UK.
Human Molecular Genetics
|October 20, 2011
Summary
Alpha-synuclein (α-synuclein) overexpression worsens Huntington
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Alpha-synuclein (α-synuclein) and mutant huntingtin are key proteins in Parkinson's disease (PD) and Huntington's disease (HD) pathology, respectively.
- Previous studies show α-synuclein overexpression impairs macroautophagy and worsens HD phenotypes in cell and Drosophila models.
- Understanding the interplay between α-synuclein and HD pathology is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the impact of α-synuclein overexpression and deletion on Huntington's disease (HD) phenotypes in mouse models.
- To assess the effect of α-synuclein deletion on macroautophagy in mouse brains.
- To establish a functional link between α-synuclein and HD pathogenesis in a mammalian system.
Main Methods:
- Utilized two N-terminal Huntington's disease (HD) mouse models (R6/1 and N171-82Q).
- Examined the effects of wild-type α-synuclein overexpression and α-synuclein deletion on HD phenotypes.
- Assessed macroautophagy by measuring autophagosome numbers in mouse brains.
Main Results:
- Overexpression of wild-type α-synuclein exacerbated tremors and influenced weight loss in both HD mouse models.
- Deletion of α-synuclein increased autophagosome numbers in HD mouse brains.
- α-synuclein deletion delayed the onset of tremors and weight loss in the HD mouse models.
Conclusions:
- Established a functional link between α-synuclein and Huntington's disease (HD) pathology in mammals.
- Wild-type α-synuclein negatively regulates autophagy, even at physiological levels.
- Findings support α-synuclein as a potential therapeutic target for Huntington's disease.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.